AAA 2024+Hear TECH Expo is complete and the continuing education opportunities were remarkable!
For ABA certificants, here are CEU requirements at a glance:
| Certified Credential | Total CEUs | Tier 1 | Professional Ethics |
| American Board of Audiology Certified (ABAC) – every year | 20 | 5 | 1 |
| Cochlear Implant Specialty Certification (CISC) – every three years | 60 (30 in cochlear implants) | 15 | 3 |
| Pediatric Audiology Specialty Certification (PASC) – every three years | 60 (30 in pediatrics) | 15 | 3 |
While the annual conference is an outstanding resource for continuing education, please remember that additional approved providers are:
- American Academy of Audiology (eAudiology)
- AudiologyOnline.org
- American Medical Association
- International Association for Continuing Education and Training (IACET)
- American Speech-Language-Hearing Association
- State audiology organizations also may be approved CE providers
Any programs that have been approved by the Academy will be reported back to the Academy if you provide your Academy web ID number when registering. This applies to non-members, as well, and it will be to your benefit in the event your required continuing education is audited.
Additional options for Tier 1 credit include:
- Authorship of a publication (up to 0.3 Tier 1 credits)
- College or university courses
- Teaching activities
- Leadership activities
See pages 13–14 in the ABA Certified Candidate Handbook for additional options for approved continued education that can be self-reported through your online user dashboard.
Recent Posts
Audiology CPT® Codes Enter Routine AMA RUC Review Process
Over the next several months, a significant number of CPT® codes used to report audiology function tests will undergo review through the AMA/Specialty Society Relative…
Academy Advocacy on Capitol Hill for Student Loan Reform and EHDI Support
Last week, Joanne Zurcher, MPP, and Academy member Melissa Heche, AuD, traveled to Capitol Hill to advocate for two important Academy priorities: protecting access to…
A New Era in Hearing Care: FDA Approves OTOF Gene Therapy
In the United States, mutations in the OTOF-gene (otoferlin gene) account for between one percent and eight percent of non-syndromic congenital hearing loss (Ford et…



